Información del producto
- β-D-Glucopyranoside, (3β,12β)-12-hydroxy-20-[(O-β-D-xylopyranosyl-(1→6)-O-β-D-glucopyranosyl-(1→6)-β-D-glucopyranosyl)oxy]dammar-24-en-3-yl 2-O-β-D-glucopyranosyl-
- (3β,12β)-12-Hydroxy-20-[(O-β-D-xylopyranosyl-(1→6)-O-β-D-glucopyranosyl-(1→6)-β-D-glucopyranosyl)oxy]dammar-24-en-3-yl 2-O-β-D-glucopyranosyl-β-D-glucopyranoside
Notoginsenoside R4 is a potent compound that has been found to have antitumor properties. It is an analog of glimepiride, which is a kinase inhibitor used in the treatment of diabetes. Notoginsenoside R4 has been shown to inhibit the growth of cancer cells and induce apoptosis in tumor cells. This compound has also been found in urine samples from Chinese subjects, indicating its potential as a biomarker for cancer diagnosis. Studies have shown that notoginsenoside R4 can inhibit the activity of kinases such as apomorphine and nintedanib, which are involved in cancer cell growth and proliferation. This makes it a promising candidate for the development of new cancer therapies and inhibitors.
Propiedades químicas
Consulta técnica sobre: 3D-MDA74177 Notoginsenoside R4
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
